Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G2/M cell cycle arrest and apoptosis Go WatanabeKevin E. BehrnsRobin D. Kim Original Article 12 December 2008 Pages: 433 - 443
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner Ana Catarina PintoJoão Nuno MoreiraSérgio Simões Original Article 23 December 2008 Pages: 445 - 454
A phase II trial evaluating capecitabine and irinotecan as second line treatment in patients with oesophago-gastric cancer who have progressed on, or within 3 months of platinum-based chemotherapy Alexandra LearyL. AssersohnJ. Oates Original Article 23 December 2008 Pages: 455 - 462
The x c − cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine Jun GuanMaisie LoYu-Zhuo Wang Original Article 24 December 2008 Pages: 463 - 472
Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of tumors implanted in rat livers by inducing platinum-DNA adducts to form and massive apoptosis Mitsuharu HanadaAkemi BabaFumio Nishikaku Original Article Open access 24 December 2008 Pages: 473 - 483
Tumor specific cytotoxicity of β-glucosylceramide: structure–cytotoxicity relationship and anti-tumor activity in vivo Hirosuke OkuChangchun LiHisami Watanabe Original Article 23 December 2008 Pages: 485 - 496
Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma Won KimJung-Hwan YoonHyo-Suk Lee Original Article 20 December 2008 Pages: 497 - 507
Application of prolonged microdialysis sampling in carboplatin-treated cancer patients Inge R. H. M. KoningsFrederike K. EngelsWalter J. Loos Original Article Open access 20 December 2008 Pages: 509 - 516
Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate S. T. RussellP. M. A. SirenM. J. Tisdale Original Article 27 December 2008 Pages: 517 - 527
Evaluation of the antitumoral effect of dihydrocucurbitacin-B in both in vitro and in vivo models Jarbas Mota SiqueiraAndressa Córneo GazolaRosa Maria Ribeiro-do-Valle Original Article 30 January 2009 Pages: 529 - 538
Activation of ER stress and inhibition of EGFR N-glycosylation by tunicamycin enhances susceptibility of human non-small cell lung cancer cells to erlotinib Yi-He LingTianhong LiMissak Haigentz Jr Original Article 08 January 2009 Pages: 539 - 548
Phase II study of paclitaxel combined with capecitabine as second-line treatment for advanced gastric carcinoma after failure of cisplatin-based regimens N. BaizeA. Abakar-MahamatF. X. Caroli-Bosc Original Article 04 January 2009 Pages: 549 - 555
A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors Kuniaki ShiraoTakayuki YoshinoShinichiro Yoshino Original Article 24 January 2009 Pages: 557 - 564
Expression of ERCC1 and class III β-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation Koichi AzumaTetsuro SasadaHisamichi Aizawa Original Article 03 January 2009 Pages: 565 - 573
Becatecarin (rebeccamycin analog, NSC 655649) is a transport substrate and induces expression of the ATP-binding cassette transporter, ABCG2, in lung carcinoma cells Robert W. RobeyTomasz ObrzutSusan E. Bates Original Article 09 January 2009 Pages: 575 - 583
Pegylated liposomal doxorubicin (CAELYX®) in patients with advanced ovarian cancer: results of a German multicenter observational study Jalid SehouliO. Camaraon behalf of the North-Eastern German Society of Gynecological Oncology (NOGGO) Original Article 21 January 2009 Pages: 585 - 591
Role of frequency and mechanical index in ultrasonic-enhanced chemotherapy in rats Bryant J. StaplesBeverly L. RoederWilliam G. Pitt Original Article 07 January 2009 Pages: 593 - 600
The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck Kazim UygunAhmet BiliciSernaz Uzunoglu Original Article 03 January 2009 Pages: 601 - 605
RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines Cao YangFrancis J. HornicekZhenfeng Duan Original Article 06 January 2009 Pages: 607 - 614
Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity Ivana TichaPetra KleiblovaZdenek Kleibl Short Communication 14 March 2009 Pages: 615 - 618
Prolonged accumulation of high-dose methotrexate in a case with large liver cysts Manabu KawakamiHiroki OmoriToshihiro Soma Short Communication 25 March 2009 Pages: 619 - 622
Improved survival in patients with breast rhabdoid tumors with multi-agent adjuvant chemotherapy combined with irradiation Yoshitaka FuruyaHironobu YanagieHiroshi Yasuhara Short Communication 26 March 2009 Pages: 623 - 627
MTT assays cannot be utilized to study the effects of STI571/Gleevec on the viability of solid tumor cell lines Jonathan T. SimsRina Plattner Short Communication 26 April 2009 Pages: 629 - 633
Response of imatinib-resistant extra-abdominal aggressive fibromatosis to sunitinib: case report and review of the literature on response to tyrosine kinase inhibitors Keith M. SkubitzJ. Carlos ManivelJerry W. Frolich Short Communication 29 April 2009 Pages: 635 - 640
Oral administration of the GnRH antagonist acyline, in a GIPET®-enhanced tablet form, acutely suppresses serum testosterone in normal men: single-dose pharmacokinetics and pharmacodynamics John Kenneth AmoryThomas W. LeonardWilliam J. Bremner Short Communication 29 May 2009 Pages: 641 - 645
